Malaria Diagnostics Market by Technology (Microscopy, Rapid Diagnostic Tests, Molecular Diagnostic Tests), End User (Hospitals, Clinics, Diagnostics Centers, and Others), and Geography - Global Forecast to 2027
“The rising demand for malaria diagnostics and the introduction of novel diagnostic techniques are the key factors driving the overall growth of the malaria diagnostics market”
The global malaria diagnostics market size is projected to reach USD 1.02 Billion by 2027 from USD 770.5 million in 2022, at a CAGR of 5.4% during the forecast period. Market is driven by factors such as rise in the prevalence of malaria in developing countries. Moreover, the surge in awareness initiatives by governments and the increase in research for new malaria diagnostics are the factors that boost the growth of this market. However, lack of alertness about healthcare in developing countries is a major factor that restricts the malaria diagnostics market growth.
To know about the assumptions considered for the study, Request for Free Sample Report
“ The Rapid Diagnostic Tests (RDTs) accounted for the largest market share in the malaria diagnostics market, by technology, during the forecast period”
Based on the technology, the market is segmented into rapid diagnostic tests (RDTs), microscopy, and molecular diagnostic tests. In 2021, rapid diagnostic tests accounted for a major market share, owing to its inexpensive, simple-to-operate and read and highly sensitive and specific features. However, molecular diagnostic tests is expected to increase significantly between 2021 and 2027 due to the accurate diagnosis offered by these tests.
“Clinics segment accounted for the largest market share”
Based on the end-user, the market is segmented into hospitals, clinics, and diagnostic centers. The clinic's segment accounted for the largest market share in 2021, while diagnostic centers is expected to grow at the fastest rate during the forecast period. This can be attributed to the rising demand for early diagnosis of falciparum malaria for better healthcare treatment and launch of advanced diagnostics facilities.
“APAC region accounted for the highest CAGR”
The global malaria diagnostics market is divided into five regions: North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa. According to the regional analysis, the Middle East and Africa is expected to occupy a substantial share of the malaria diagnostics industry in 2021. This growth can be attributed to the growing prevalence of malaria in the region caused by the widespread malaria vector, Anopheles gambiae, which is difficult to control. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period due to the increasing awareness regarding the use of malaria diagnostic devices.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
- By Designation: C-level - 27%, D-level - 18%, and Others - 55%
- By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and the Middle East & Africa – 4%
To know about the assumptions considered for the study, download the pdf brochure
Lits of Companies Profiled in the Report:
- Access Bio., Inc.
- Abbott Laboratories
- Premier Medical Corporation Pvt. Ltd.
- Sysmex Partec GmbH
- bioMérieux
- Beckman Coulter, Inc.
- Siemens Healthineers
- Leica Microsystems GmbH
- Nikon Corporation
- Olympus Corporation
- Bio-Rad Laboratories, Inc.
- Meril Life Sciences Pvt Ltd
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKETS COVERED
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 MARKET SCOPE
1.5 MARKET STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key data from primary sources
2.2.2.2 Key industry insights
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
2.6 GROWTH RATE ASSUMPTIONS
2.7 LIMITATIONS
2.8 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increase in prevalence of malaria
5.2.1.2 Surge in healthcare expenditure worldwide
5.2.1.3 Rise in technologically advanced and efficient malaria diagnostics across the globe
5.2.2 RESTRAINTS
5.2.2.1 Increasing number of countries in the malaria elimination phase
5.2.2.2 Demand for low-cost malaria diagnostic tests
5.2.3 OPPORTUNITIES
5.2.3.1 High growth potential in developing economies
5.2.4 OPPORTUNITIES
5.2.4.1 A lack of healthcare understanding is a major factor limiting the development
5.3 TECHNOLOGY ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.7 PORTER’S FIVE FORCES ANALYSIS
6 MALARIA DIAGNOSTICS MARKET, BY TECHNOLOGY (USD MILLION)
6.1 INTRODUCTION
6.2 MICROSCOPY
6.3 RAPID DIAGNOSTIC TESTS
6.4 MOLECULAR DIAGNOSTIC TESTS
7 MALARIA DIAGNOSTICS MARKET, BY END USER
7.1 INTRODUCTION
7.2 HOSPITALS
7.3 CLINICS
7.4 DIAGNOSTICS CENTERS
7.5 OTHERS
8 MALARIA DIAGNOSTICS MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 US
8.2.2 CANADA
8.3 EUROPE
8.3.1 GERMANY
8.3.2 UK
8.3.3 FRANCE
8.3.4 ITALY
8.3.5 SPAIN
8.3.6 REST OF EUROPE
8.4 ASIA PACIFIC
8.4.1 CHINA
8.4.2 JAPAN
8.4.3 INDIA
8.4.4 REST OF ASIA PACIFIC
8.5 LATIN AMERICA
8.6 MIDDLE EAST & AFRICA
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
9.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
9.4 MARKET SHARE ANALYSIS
9.5 COMPANY EVALUATION QUADRANT
9.6 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES (2020)
9.7 COMPETITIVE BENCHMARKING
9.8 COMPETITIVE SCENARIO
10 COMPANY PROFILES
10.1 KEY PLAYERS
(Business Overview, Products and Services Offered, Recent Developments, MnM View, Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) *
10.1.1 ACCESS BIO, INC.
10.1.2 ABBOTT
10.1.3 PREMIER MEDICAL CORPORATION LTD
10.1.4 SYSMEX PARTEC GMBH
10.1.5 BIOMERIEUX
10.1.6 BECKMAN COULTER, INC.
10.1.7 SIEMENS HEALTHINEERS
10.1.8 LEICA MICROSYSTEMS GMBH
10.1.9 NIKON CORPORATION
10.1.10 OLYMPUS CORPORATION
10.1.11 BIO-RAD LABORATORIES, INC.
10.1.12 MERIL LIFE SCIENCES PVT LTD
*Details on Business Overview, Products and Services Offered, Recent Developments, MnM View, Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats might not be captured in case of unlisted companies.
11 APPENDIX
11.1 INDUSTRY INSIGHTS
11.2 DISCUSSION GUIDE
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’SUBSCRIPTION PORTAL
11.4 AVAILABLE CUSTOMIZATIONS
11.5 RELATED REPORTS
11.6 AUTHOR DETAILS
Growth opportunities and latent adjacency in Malaria Diagnostics Market